New Drug Applications

FDA Accepts Remoxy NDA For Review

7 years ago
by David Miller
967 Views
Written by David Miller

AUSTIN, Texas, March 01, 2018 (GLOBE NEWSWIRE) — Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today that the U.S. Food and Drug Administration (FDA) has determined that a New Drug Application (NDA) for Remoxy ER, the Company’s lead drug…Original Article

You may also like

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

Don`t Leave Yet!

Thank you!

[mwai_chat window="true" fullscreen="true"]